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                Protective immunity to tuberculosis depends 
on CD4  +   T lymphocytes in humans and in mice 
(  1, 2  ), but adaptive immune responses are un-
able to eradicate   Mycobacterium tuberculosis   or to 
provide sterile immunity. One characteristic of 
the adaptive immune response to tuberculosis is 
the long interval required for its development 
compared with the response to immunization 
or to other infections. In humans, development 
of adaptive immunity to tuberculosis, which is 
measured as a response to a tuberculin skin test, 
requires up to 5  –  6 wk after infection (  3, 4  ), 
whereas in mice, the earliest antigen-specifi  c 
CD4  +   T cell responses require a minimum of 
12 d after aerosol infection (  5  ). Although these 
intervals are much longer than those required 
for development of adaptive immune responses 
to other pathogens such as   Salmonella enterica, 
Listeria monocytogenes, Francisella tularensis,   Infl  u-
enza virus  , Leishmania major,   or   Plasmodium yoelii   
sporozoites (  6  –  12  ), the mechanisms that account 
for the delay in adaptive immune responses in 
tuberculosis are poorly understood. Indeed, the 
mechanisms that underlie the initiation of adaptive 
immune responses to   M. tuberculosis   are them-
selves poorly understood. One prior study re-
vealed that antigen-specifi  c CD4  +   T lymphocytes 
did not appear in the lung-draining mediastinal 
lymph node until after   M. tuberculosis   had dis-
seminated to that lymph node, indicating that, 
whereas   M. tuberculosis   is a lung pathogen residing 
in antigen-presenting cells, the adaptive immune 
response to   M. tuberculosis   antigens is initiated 
in the local lymph node (  5  ). That study also found 
that bacteria and T cell recall responses appear ear-
lier in the mediastinal lymph nodes of C57BL/6 
than in C3H/HeJ mice infected with   M. tubercu-
losis  , but it did not address the mechanisms of 
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  The onset of the adaptive immune response to   Mycobacterium tuberculosis   is delayed 
compared with that of other infections or immunization, and allows the bacterial popula-
tion in the lungs to expand markedly during the preimmune phase of infection. We used 
adoptive transfer of   M. tuberculosis   Ag85B-specifi  c CD4  +   T cells to determine that the 
delayed adaptive response is caused by a delay in initial activation of CD4  +   T cells, which 
occurs earliest in the local lung-draining mediastinal lymph node. We also found that 
initial activation of Ag85B-specifi  c T cells depends on production of antigen by bacteria in 
the lymph node, despite the presence of 100-fold more bacteria in the lungs. Although 
dendritic cells have been found to transport   M. tuberculosis   from the lungs to the local 
lymph node, airway administration of LPS did not accelerate transport of bacteria to the 
lymph node and did not accelerate activation of Ag85B-specifi  c T cells. These results 
indicate that delayed initial activation of CD4  +   T cells in tuberculosis is caused by the 
presence of the bacteria in a compartment that cannot be mobilized from the lungs to the 
lymph node, where initial T cell activation occurs. 
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depicted) and with control of bacterial growth (  Fig. 1  ). During 
the time required for appearance of an adaptive immune re-
sponse to   M. tuberculosis   in the lungs, the bacterial population 
expanded   >  20,000-fold, and although the adaptive immune 
response is capable of arresting progressive growth of the bac-
teria, it does not lead to apparent bacterial killing. 
  The long interval between infection and appearance of 
adaptive immunity to   M. tuberculosis   could be attributable to 
delayed priming of naive antigen-specifi  c T lymphocytes, or 
to delayed traffi   cking of eff  ector T lymphocytes to the site of 
infection. To determine the contributions of these two steps 
to the time required for appearance of   M. tuberculosis  –    specifi  c 
T lymphocytes in the lungs, we used CD4  +   T lymphocytes 
from transgenic mice that express a T-cell antigen receptor, 
termed P25TCR-Tg, which is specifi  c for peptide 25 (aa 
240  –  254) of   M. tuberculosis   Antigen 85B. 
  P25TCR-Tg CD4  +   T cells recognize Antigen 85B produced 
by   M. tuberculosis   
  We fi  rst assessed the ability of P25TCR-Tg CD4  +   T cells to 
respond to antigen presented by cultured cells. Splenocytes 
from P25TCR-Tg mice stimulated with peptide antigen 
(peptide 25) and whole Antigen 85B (Ag85B) responded in a 
dose-dependent manner with maximal responses achieved at 
10     g/ml for both peptide 25 and native Ag85 isolated from 
  M. tuberculosis   (Fig. S1, available at http://www.jem.org/cgi/
content/full/jem.20071367/DC1). In addition, naive P25TCR-
Tg/Rag1      /      CD4  +   T cells responded to Ag85B expressed by 
  M. tuberculosis   in cultured macrophages by producing IFN     and 
proliferating (Fig. S1). These results confi  rm that P25TCR-Tg 
CD4  +   T cells are capable of sensitive detection of Ag85B pro-
duced by live, intracellular   M. tuberculosis  . 
  Proliferation of Ag85B-specifi  c CD4  +   T cells begins 
in the mediastinal lymph node, and is delayed until 11 d 
after infection 
  To characterize the time and location of  M. tuberculosis   Ag85B-
specifi  c T cell priming after   M. tuberculosis   infection in vivo, 
we adoptively transferred CFSE-labeled P25TCR-Tg CD4  +   
T cells into CD45.1 congenic wild-type mice (  14  ). After 
adoptive transfer, the P25TCR-Tg CD4  +   T cells traffi   cked to 
secondary lymphoid tissues and represented an equal percent-
age (1.3%) of the CD4  +   T cells in all of the secondary lym-
phoid tissues examined, as well as in the lungs and blood 
(unpublished data). When examined 7 or 11 d after aerosol 
infection with   M. tuberculosis   (    100 cfu/mouse), a single pop-
ulation of CFSE  bright   P25TCR-Tg CD4  +   T cells was detected 
in the lungs and mediastinal lymph node, indicating that none 
of the cells had proliferated (  Fig. 2 A  ).   14 d after infection, a 
small percentage of the P25TCR-Tg CD4  +   T cells had pro-
liferated in the mediastinal lymph node, but not in other 
  tissues examined (lung, spleen, and inguinal lymph node). Be-
cause some P25TCR-Tg CD4  +   T cells had undergone up to 
7 cycles of replication, we estimated that proliferation had begun 
(but was not completed) on day 11, assuming     10.6 h per cell 
cycle (  15  ). This was confi  rmed in a subsequent experiment 
dissemination of the bacteria from the lungs to the mediastinal 
lymph node. 
  We recently reported that, in addition to macrophages, 
dendritic cells are infected with   M. tuberculosis   with high fre-
quency in the lungs and mediastinal lymph node of mice, and we 
reported evidence that dendritic cells transport   M. tuberculosis   
from the lungs to the mediastinal lymph node (  13  ). In these 
studies, we used adoptive transfer of CD4  +   T cells that ex-
press a transgenic T cell antigen receptor specifi  c for a pep-
tide from   M. tuberculosis   Antigen 85B to characterize the 
spatial and temporal determinants of initiation of the adaptive 
immune response to   M. tuberculosis  . We found that activation 
of CD4  +   T cells in the mediastinal lymph node is the limiting 
step in development of the adaptive immune response, and 
that after initial proliferation in the lymph node, eff  ector 
CD4  +   T cells traffi   c rapidly to the lungs. We also found that 
initial CD4  +   T cell responses depend on the presence of bac-
teria in the mediastinal lymph node, and that before dissemi-
nation in the lymph node, the bacteria are in a compartment 
in the lungs that cannot be mobilized to the lymph node by an 
additional proinfl  ammatory stimulus. These fi  ndings indicate 
that initiation of an adaptive immune response to   M. tuberculosis   
depends on transport of live bacteria from the lungs to the medi-
astinal lymph node, and that   M. tuberculosis   may delay this process 
to expand the bacterial population in the lungs and to evade 
immune eff  ector mechanisms and establish chronic infection. 
    RESULTS   
  The adaptive immune response to   M. tuberculosis   
in the lungs is delayed and has limited effi  cacy 
  In wild-type C57BL/6 mice infected by the aerosol route, 
  M. tuberculosis   grows progressively in the lungs for     17  –  19 d 
(  Fig. 1  ).   Coincident with the appearance of a detectable adap-
tive immune response, the bacterial population stops expand-
ing, and reaches a stable plateau. IFN    , which is primarily 
produced by CD4  +   T cells, is one measure of adaptive immunity 
to   M. tuberculosis  , and its expression in the lungs coincides 
with the appearance of CD4  +   and CD8  +   T lymphocytes (not 
    Figure 1.         Timing of the appearance of adaptive immunity compared 
with bacterial growth in the lungs of   M. tuberculosis    –  infected 
C57BL/6 mice.   C57BL/6 mice were infected by the aerosol route with 50 cfu 
of   M. tuberculosis   (H37Rv). At designated time points, the lungs were 
removed and assayed for bacteria by plating and for IFN     gene  expression 
by real-time RT-qPCR. Four mice were assayed at each time point. Error 
bars represent the SEM.     JEM VOL. 205, January 21, 2008 
ARTICLE
107
with the regulation of T cell egress from the lymph node by 
sphingosine-1-phosphate and its receptor after initial T cell 
activation (  16  ). Further evidence that Ag85B-specifi  c CD4  +   
T cells are recruited to the lungs after proliferating in the 
mediastinal lymph node was provided by the observation 
that the total number of P25TCR-Tg CD4  +   T cells in the 
lungs increases coincident with a decrease in the number of 
P25TCR-Tg CD4  +   T cells in the mediastinal lymph node 
(  Fig. 2 B  ). The observation that the number of P25TCR-Tg 
CD4  +   T cells in the lung does not equal the number pro-
duced in the mediastinal lymph node is likely caused by the 
death of a large number of the cells that initially proliferated 
in the mediastinal lymph node (  17  ). These observations with 
P25TCR-Tg CD4  +   T cells are likely to be representative of 
overall   M. tuberculosis   antigen-specifi  c CD4  +   T cell responses, 
as the increases in P25TCR-Tg CD4  +   T cells in the lung mirror 
the overall increase in CD4  +   T cells in the lung (  Fig. 2 C  ). 
  We considered the possibility that the delayed initial acti-
vation of P25TCR-Tg CD4  +   T cells was a consequence of 
the number of cells administered because adoptive transfer of 
large numbers of TCR transgenic CD4  +   T cells infl  uences 
their ex  tent of expansion (  18  ), diff  erentiation (  19  ), and sur-
vival (  20  ). However, adoptive transfer of lower numbers (in 
10-fold dilutions to as low as 10  3   cells/mouse) of P25TCR-Tg 
CD4  +   T cells did not result in a detectable decrease in the 
time required for their initial activation after   M. tuberculosis   
in which     4% of the P25TCR-Tg CD4  +   T cells in 5 mice 
were in the fi  rst 2 cycles of proliferation in the mediastinal 
lymph node on day 12 after infection (unpublished data). By day 
17 of infection, the absolute number of P25TCR-Tg CD4  +   
T cells in the mediastinal lymph node reached a peak after 
expanding 110-fold, and accounted for 8% of the CD4  +   T cells 
in the mediastinal lymph node. 
    M. tuberculosis   Ag85B-specifi  c CD4  +   T cells traffi  c 
to the lungs after proliferating in the mediastinal 
lymph node 
  We also assessed Ag85B-specifi  c T cell proliferation in the lungs. 
Few (2   ×   10  5  ) CD4  +   T cells were found in the lung before 
infection and during the fi  rst week of infection, of which 1.03% 
were P25TCR-Tg CD4  +   cells. After 14 d of infection, when 
T cell proliferation was detectable in the mediastinal lymph 
node, none of the P25TCR-Tg CD4  +   T cells had prolifer-
ated in the lungs (  Fig. 2 A  ). By day 17 after infection, when 
a high proportion of the P25TCR-Tg CD4  +   T cells were ac-
tively proliferating in the mediastinal lymph node, P25TCR-
Tg CD4  +   T cells in the lung were either CFSE  high   or CFSE  low  , 
with few cells of intermediate CFSE intensity. The lack of 
cells in the fi  rst 3 cycles of proliferation in the lungs at those 
time points indicates that the CFSE low-to-negative cells had 
migrated to the lungs after undergoing several cycles of pro-
liferation in the lymph node. This observation is consistent 
    Figure 2.         Proliferation of P25TCR-Tg CD4  +   T cells occurs in the mediastinal lymph node 11 d after infection.   (A) CFSE proliferation profi  le of 
P25TCR-Tg CD4  +   T cells in the mediastinal lymph node and lungs over the course of the infection with   M. tuberculosis  . Plots are representative of fi  ve 
mice at each time point. Data from days 7, 14, 17, and 21 are from one experiment; day 11 results are from a separate experiment, using the same bacterial 
inoculum and number of adoptively transferred cells. (B) Total number of P25TCR-Tg CD4  +   T cells in the mediastinal lymph node (solid line) and lung 
(dashed line). Replicates were averaged, and the error bars represent the SEM of fi  ve mice per time point. (C) Comparison of the number of total CD4  +  
T cells and the P25TCR-Tg CD4  +   T cells in the lungs with time. Error bars represent the mean   ±   the SD.     108 INITIATION OF T CELL RESPONSES TO   MYCOBACTERIUM TUBERCULOSIS   | Wolf et al.
were expressed before the appearance of cells that had previ-
ously proliferated (Fig. S3), further supporting the conclusion 
that initial CD4  +   T cell activation occurs before recruitment 
to the lungs. Likewise, cells that were competent for IFN     
production did not appear in the lungs until the arrival of 
P25TCR-Tg CD4  +   T cells that had previously proliferated 
(4 or more cycles) outside the lungs. 
  Delayed activation of   M. tuberculosis  –    specifi  c CD4  +   T cells 
is not solely caused by a low bacterial inoculum 
  Because infection with   M. tuberculosis   was routinely established 
with a small bacterial inoculum (    100 cfu), it is possible that 
one determinant of the delay in initiation of adaptive immune 
responses is the abundance of antigen, especially because 
  M. tuberculosis   replicates slowly. To assess this possibility, we 
infected four groups of mice by the aerosol route with a range 
of bacterial inocula between 15 and 700 cfu per mouse and 
assessed proliferation of adoptively transferred P25TCR-Tg 
CD4  +   T cells during the fi  rst 24 d of infection. In the lungs, 
each inoculum resulted in a distinct bacterial burden over the 
infection (unpublished data). We also considered the possibility 
that the long interval required for activation of P25TCR-Tg 
CD4  +   T cells was an intrinsic property of the cells, or was the 
consequence of the route of antigen delivery. Therefore, we 
examined the proliferation of P25TCR-Tg CD4  +   T cells after 
administration of recombinant Ag85B by the respiratory and 
subcutaneous routes. This revealed that adoptively transferred 
P25TCR-Tg CD4  +   T cells could respond by proliferating ex-
tensively in vivo within 3 d of immunization, irrespective of 
the route of antigen delivery (Fig. S2, available at http://www
.jem.org/cgi/content/full/jem.20071367/DC1). These fi  nd-
ings indicate that the delayed initial activation of P25TCR-Tg 
CD4  +   cells in vivo after   M. tuberculosis   infection is not attribut-
able to an artifact of the experimental system. 
  P25TCR-Tg CD4  +   T cell responses are specifi  c 
for Antigen 85B 
  To characterize the specifi  city of P25TCR-Tg CD4  +   T cells 
in vivo, we infected mice with an Antigen 85B  –  null strain of 
  M. tuberculosis   (Ag85BKO-Mtb). After aerosol infection, the 
Ag85BKO-Mtb strain grew in the lungs and disseminated 
to the mediastinal lymph node at a rate equivalent to that 
of wild-type   M. tuberculosis   H37Rv (  Fig. 3 A  ).   Nevertheless, 
P25TCR-Tg CD4  +   T cell proliferation was not detectable in 
the mediastinal lymph node or in the lung, even as late as 27 d 
after infection (  Fig. 3 B  ). The results demonstrate that all the 
P25TCR-Tg CD4  +   T cell proliferation detected in vivo was 
Antigen 85B specifi  c. Additionally, the lack of any response in 
the absence of antigen implies a lack of expansion of bystander 
CD4  +   T cells during the initial phase of   M. tuberculosis   infection. 
  Analysis of T cell activation markers and IFN     production 
  We also considered the possibility that   M. tuberculosis    –  specifi  c 
CD4  +   T cells might become partially activated earlier in infec-
tion, but that there is an abnormally long lag period between 
initial activation and proliferation. We therefore assessed ex-
pression of the early activation marker CD69, as well as CD25 
expression on the surface of P25TCR-Tg CD4  +   T cells dur-
ing the course of infection. CD69 expression on P25TCR-Tg 
CD4  +   T cells was fi  rst observed on day 12, which is approxi-
mately coincident with the beginning of measurable prolif-
eration in the mediastinal lymph node, although 5% more 
of the P25TCR-Tg CD4  +   T cells had up-regulated CD69 
than had begun to proliferate, indicating that CD69 is up-
regulated before proliferation begins (Fig. S3, available at 
http://www.jem.org/cgi/content/full/jem.20071367/DC1). 
The percentage of CD25  +   P25TCR-Tg CD4  +   T cells increased 
concurrent with the onset of proliferation in the mediastinal 
lymph node (Fig. S3). In addition, a small percentage (4%) of 
the adoptively transferred cells were competent to produce IFN    
by day 14 of infection; the percentage of IFN    -producing 
P25TCR-Tg cells increased further between 14 and 17 d after 
infection, and was highest in cells that had undergone 4 or 
more cycles of cell division (Fig. S3). 
  Analysis of CD69 and CD25 expression on P25TCR-Tg 
CD4  +   cells in the lungs revealed that neither of these markers 
    Figure 3.         P25TCR-Tg CD4  +   T cell responses are specifi  c for   M. tu-
berculosis   Antigen 85B.   (A) CFSE-labeled CD4  +   P25TCR-Tg  CD4 +   T  cells 
were adoptively transferred into C57BL/6J mice, and after 24 h, mice were 
infected with either wild-type   M. tuberculosis   (Wt-Mtb, solid lines) or 
Antigen 85BKO   M. tuberculosis   (Ag85BKO-Mtb, dashed lines with open 
symbols) by the aerosol route. The initial inoculum for both strains was 
    100 bacteria/mouse. Total bacterial load was assessed over the fi  rst 28 d 
of infection in the lungs (circles) and the mediastinal lymph node (squares). 
At each time point, two Ag85BKO-Mtb  –  infected mice were assessed with 
a difference of   <  0.5 log  10  . Error bars for WT-Mtb represent the mean   ±   the 
SD of fi  ve mice. The dashed line represents the limit of detection for the 
cfu assay (18.75 cfu/mouse). The mediastinal lymph node cfu of all the 
mice at day 7 were below the limit of detection. (B) CFSE proliferation 
profi  le of P25TCR-Tg CD4  +   T cells in the mediastinal lymph node.     JEM VOL. 205, January 21, 2008 
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the source of antigen for initial stimulation of Ag85B-specifi  c 
CD4  +   T cells is in the lungs or in the mediastinal lymph node 
(which have     100-fold fewer bacteria than the lungs), we 
tested the hypothesis that stimulation of CD4  +   T cells de-
pends on the number of bacteria in the lymph node by exam-
ining the relationship between the number of bacteria in the 
mediastinal lymph node and proliferation of adoptively trans-
ferred P25TCR-Tg cells. We pooled the results of three in-
dependent experiments and plotted the log  10   mediastinal 
lymph node cfu versus the percentage of P25TCR-Tg CD4  +   
T cells that had proliferated in the mediastinal lymph node 
for each mouse. The resulting plot revealed that no prolifera-
tion occurred when there were fewer than     1,500 cfu in the 
mediastinal lymph node, even when there were as many as 
5   ×   10  4   cfu in the lungs. However, once a threshold number 
of bacteria (1,500  –  3,000 per lymph node) were present in the 
lymph node, there was a linear correlation between cfu and 
the percentage of P25TCR-Tg CD4  +   T cells that proliferated 
(r  2   = 0.77;   Fig. 4 C  ). 
  When lung cfu were plotted against the mediastinal lymph 
node cfu, there was little correlation between the lung cfu 
and the lymph node cfu in individual mice early in infection, 
when lung cfu were   <  5 log  10   (  Fig. 4 D  ). When we analyzed 
course of the infection, with a 2 log  10   diff  erence between the 
highest and lowest dose at each time point (  Fig. 4 A  ).   Varying 
the inoculum also resulted in a 2 log  10   diff  erence in bacteria in 
the mediastinal lymph node in mice that received the highest 
and lowest inocula (  Fig. 4 B  ). This revealed that decreasing 
the initial inoculum below 30 cfu/mouse led to an additional 
3 d delay in P25TCR-Tg CD4  +   T cell proliferation, whereas 
increasing the inoculum to 700 cfu/mouse did not lead to 
earlier proliferation, but caused a slight increase in the fraction 
of the cells that proliferated by day 14 (  Fig. 4 B  ). These results 
indicate that, whereas initial activation of Ag85B-specifi  c CD4  +   
T cells is partially sensitive to the number of bacteria admin-
istered, the delay between initial infection and the earliest 
activation of CD4  +   T cells could not be attributed solely to the 
low number of bacteria used to initiate infection. 
  Initial activation of   M. tuberculosis  –    specifi  c CD4  +   T cells 
is determined by the number of bacteria in the mediastinal 
lymph node 
  Because naive T lymphocytes traffi   c to the lungs and other 
peripheral tissues with low frequency, it was not surprising 
that activation of   M. tuberculosis    –  specifi  c T cells occurred ear-
liest in the mediastinal lymph node. To determine whether 
    Figure 4.         Dependence of initiation of proliferation on the inoculum of   M. tuberculosis  .   Bacterial cfu in the lung (A) and mediastinal lymph node 
(B) over the course of the infection after inocula of   <  15, 30, 100, or 700 bacteria per mouse. (B) Histograms are representative of P25TCR-Tg CD4  +   T  cell 
proliferation in the mediastinal lymph node 14 (left column) or 17 (right column) d after infection in mice that received the designated inocula. (C) Cor-
relation of mediastinal lymph node bacterial burden and proliferation of P25TCR-Tg CD4  +   T cells. Data are from three independent experiments, and 
  include data from mice that received distinct inocula and that were harvested on various days after infection. (D) Correlation of lung and mediastinal 
lymph node cfu and P25TCR-Tg CD4  +   T cell proliferation. Six mice with similar lung cfu and dissimilar mediastinal lymph node cfu are highlighted. 
Inset table shows the log  10   lung cfu (Lung), log  10   mediastinal lymph node cfu (LN), and the percentage of P25TCR-Tg CD4  +   T cells that had undergone 
one or more cycles of proliferation in the mediastinal lymph node for each of the highlighted mice.     110 INITIATION OF T CELL RESPONSES TO   MYCOBACTERIUM TUBERCULOSIS   | Wolf et al.
do not drain the lungs, further supports the conclusion that 
CD4  +   T cell activation requires synthesis of antigens in the lo-
cal lymph node, and that production of   M. tuberculosis   antigens 
in the lungs plays little, if any, role in initiating responses of 
naive T lymphocytes. 
  In the spleen, we found that on day 14 of infection there 
were   >  10-fold fewer bacteria in the spleen compared with 
the mediastinal lymph node (  Fig. 6 B  ). The diff  erence in bac-
terial load narrowed over the next 2 wk of the infection. 
Proliferation of P25TCR-Tg CD4  +   T cells occurred in the 
spleen, but followed T cell responses in the mediastinal lymph 
node by     3 d (  Fig. 6 A  ). At the point when P25TCR-Tg 
CD4  +   T cell proliferation occurred in the spleen (day 17), the 
bacterial load in the spleen had reached approximately the 
same level as in the mediastinal lymph node when initial pro-
liferation was detected. 
  Addition of a proinfl  ammatory stimulus does not accelerate 
the T cell response to live   M. tuberculosis   
  The observations that the initial adaptive immune response to 
an   M. tuberculosis   is delayed, that activation of   M. tuberculosis    –
  specifi  c CD4  +   T cells depends on bacterial production of an-
tigen in the lymph node, and that the number of bacteria in 
the lymph node is only     1% of that in the lung suggest that 
  M. tuberculosis   might impair maturation and/or traffi   cking of 
dendritic cells from the lungs to the lymph node. To test this 
hypothesis, we administered LPS intranasally (i.n.) to mice that 
had been infected with wild-type   M. tuberculosis   10 d earlier. 
The administration of LPS resulted in a 12.4-fold increase in the 
number of myeloid dendritic cells (CD11c  hi  CD11b  hi  ) in the 
lungs, and in a 12-fold increase in myeloid dendritic cells re-
cruited to the mediastinal lymph node (  Fig. 7 A  ).   The increase 
a subgroup of mice with lung bacterial loads in the narrow 
range between 4.33 and 4.71 log  10   cfu, individual mice ex-
hibited a broad range (1.24  –  4.7 log  10  ) in the number of bac-
teria in the mediastinal lymph node. In these mice, proliferation 
of P25TCR-Tg CD4  +   T cells also exhibited a broad variation 
(1.2  –  40%), and correlated closely with the number of bacteria 
in the lymph node and not in the lung. Thus, we conclude 
that the timing of CD4  +   T cell activation is tightly linked to 
the number of bacteria in the mediastinal lymph node. 
  Delayed bacterial dissemination to the mediastinal lymph 
results in delayed T cell activation 
  We recently reported that plt mice, which lack expression of 
the CCR7 ligands CCL19 and CCL21ser, exhibit defective 
traffi   cking of   M. tuberculosis   from the lungs to the mediasti-
nal lymph node (  13  ). If initiation of CD4  +   T cell responses to 
  M. tuberculosis   depends on the number of bacteria expressing 
antigen in the lymph node, then plt mice should exhibit de-
layed activation of   M. tuberculosis  –    specifi  c CD4  +   T cells in the 
mediastinal lymph node. To test this hypothesis, we adop-
tively transferred CFSE-labeled P25TCR-Tg CD4  +   T cells 
into   M. tuberculosis  –    infected wild-type and plt mice and assessed 
the timing of T cell proliferation. 14 d after infection, when 
antigen-specifi  c CD4  +   T cell proliferation was detected in 
wild-type mice, 50% fewer P25TCR-Tg CD4  +   T cells had 
started to divide in plt mice at the same time point (  Fig. 5 A  ). 
The reduced T cell proliferation in plt mice was accompa-
nied by a 40% reduction in the number of bacteria in the 
mediastinal lymph node compared with wild-type mice at 
day 14 (  Fig. 5 B  ).   Overall, the CD4  +   T cell responses were 
delayed by     3 d in plt mice. 
  Ag85B-specifi  c T cell proliferation occurs in nondraining 
lymph nodes and spleen if suffi  cient bacteria are present in 
the tissue 
  To further test the hypothesis that activation of   M. tuberculosis  –
    specifi  c CD4  +   T cells requires production of antigen by bac-
teria in the lymph node, rather than occurring by transfer of 
soluble antigen synthesized by bacteria in the lungs, we as-
sessed proliferation of P25TCR-Tg CD4  +   T cells in the ingui-
nal lymph node, which does not receive lymphatic drainage 
from the lungs. This revealed that activation and proliferation 
of Ag85B-specifi  c CD4  +   T cells could be initiated in the in-
guinal lymph node after aerosol infection with   M. tuberculosis   
(  Fig. 6 A  ).   The timing of P25TCR-Tg CD4  +   T cell prolifera-
tion in the inguinal lymph node followed responses in the me-
diastinal lymph node by 7  –  10 d, and varied more from mouse 
to mouse than did responses in the mediastinal lymph node. 
Nevertheless, proliferative responses in the inguinal lymph 
node correlated closely with the number of bacteria present in 
the lymph node (  Fig. 6, B and C  ). Additionally, we found that 
lymph nodes in diverse anatomical locations could be sites of 
proliferation of P25TCR-Tg CD4  +   T cells, if they contained 
suffi   cient numbers of viable   M. tuberculosis   (unpublished data). 
The initiation of proliferation of   M. tuberculosis    –  specifi  c CD4  +   
T cells in lymph nodes that contain viable   M. tuberculosis  , but 
    Figure 5.         Delayed dissemination of   M. tuberculosis   in plt mice 
results in further delayed T cell activation.   (A) Proliferation of CFSE-
labeled P25TCR-Tg CD4  +   T cells after adoptive transfer to   M. tuberculosis –
   infected wild-type C57BL/6J or plt mice. Results shown are the percentage 
of P25TCR-Tg CD4  +   T cells that had started to divide, to correct for the 
partial defect in the number of adoptively transferred cells that traffi  cked 
to the mediastinal lymph node of plt mice. To detect P25TCR-Tg CD4  +  
T cells on days 10 and 14, it was necessary to pool lymph nodes from 
5 mice, therefore statistical analysis was not done on those samples. Error 
bars on days 19 and 21 represent the mean   ±   the SD of 3 C57BL/6J mice 
and 5 plt mice. *, P   <   0.05 by Student  ’  s   t   test. The percentage of CD69  +  
P25TCR-Tg CD4  +   T cells was also fourfold lower in plt mice compared with 
wild-type at day 14 (not depicted). (B) Bar graph displaying the percentage 
of P25TCR-Tg CD4  +   T cells that had divided and the cfu at days 14 and 19 
for the plt mice as the percentage of wild-type levels.     JEM VOL. 205, January 21, 2008 
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in the lungs. We propose that this allows the large bacterial 
population to resist eff  ector mechanisms of the adaptive immune 
response, and allows   M. tuberculosis   to persist in the lungs. 
  Antigen 85B is an abundant secreted protein of   M. tuber-
culosis   that represents   >  20% of the protein in culture fi  ltrates, 
and is expressed and secreted by   M. tuberculosis   within host 
cells (  21, 22  ). As a secreted protein and frequent target of im-
mune responses in humans (  23  ) and mice, Ag85B has been 
considered to be a potential candidate vaccine antigen, and a 
recombinant BCG strain that overproduces Ag85B is cur-
rently being prepared for human clinical trials. Because Ag85B 
is secreted, has been observed in extraphagosomal vesicles of 
macrophages (  22  ), and expression has been detected in the 
lungs early during infection (  24  ), we expected that produc-
tion and secretion of Ag85B by   M. tuberculosis   in the lungs 
would be sufficient to deliver soluble antigen to activate 
Ag85B-specifi  c CD4  +   T cells in the local draining lymph 
node. If this were the case, Ag85B-specifi  c T cell responses in 
the lymph node should directly correlate with the number of 
bacteria in the lungs. Instead, we found that although the 
number of bacteria in the lungs increases progressively during 
the fi  rst 2  –  3 wk of infection, Ag85B-specifi  c CD4  +   T cell re-
sponses were not observed until a threshold number of viable 
bacteria (    1,500  –  3,000) appeared in the mediastinal lymph 
node. Moreover, although the number of bacteria in the 
lymph node in most mice was closely related to (and     100-
fold less than) the number of bacteria in the lungs, analysis of 
several mice with discordant bacterial burdens in the lungs 
and lymph node revealed that responses of Ag85B-specifi  c 
CD4  +   T cells correlated with the number of bacteria in the 
mediastinal lymph node, and not with the number of bacteria in 
the lungs. Additional evidence that production of Ag85B by 
live bacteria in the lymph node is essential to initiate T cell re-
sponses in the context of   M. tuberculosis   infection was pro-
vided by analysis of Ag85B-specifi  c CD4  +   T cell responses in 
lymph nodes that do not drain the lungs. This analysis re-
vealed that Ag85B-specifi  c CD4  +   T cell responses occurred 
in peripheral (nonlung draining) lymph nodes as long as a 
suffi   cient number of live bacteria were present in the same 
in the number of myeloid dendritic cells was accompanied by 
their increased maturation, as assessed by surface expression of 
MHC class II (  Fig. 7 B  ). However, despite the increased number 
of dendritic cells in the lungs and mediastinal lymph node, 
there was no increase in the number of bacteria transported to 
the mediastinal lymph node from the lungs (  Fig. 7 C  ), and 
there was no increase in proliferation of P25TCR-Tg CD4  +   
T cells in the mediastinal lymph node after treatment with LPS 
(  Fig. 7 D  ), unless recombinant Ag85B was coadministered 
with LPS (  Fig. 7 E  ). 
    DISCUSSION   
  The adaptive cellular immune response to   M. tuberculosis   is 
only partially effi   cacious, as it can restrict progressive growth 
of the bacteria, but rarely if ever eradicates them. In our stud-
ies, we used adoptive transfer of cells from transgenic mice 
whose CD4  +   T lymphocytes express an antigen receptor spe-
cifi  c for a peptide from   M. tuberculosis   Antigen 85B to char-
acterize the initial events in the adaptive immune response to 
  M. tuberculosis  . In accord with studies that used ex vivo T cell 
restimulation to characterize the location and timing of CD4  +   
T cell responses to   M. tuberculosis  , we found that the earliest 
detectable responses of adoptively transferred Ag85B-specifi  c 
CD4  +   T cells occur in the lung-draining mediastinal lymph 
node, are delayed until 10  –  12 d after infection, and are pre-
ceded by the appearance of live   M. tuberculosis   in the medias-
tinal lymph node. In addition, we found strong evidence that 
activation of Ag85B-specifi  c CD4  +   T cells depends on the 
number of   M. tuberculosis   in the lymph node rather than in 
the lungs. We also found that transfer of   M. tuberculosis   from 
the lungs to the lymph node could not be accelerated by pul-
monary administration of LPS, indicating that early in infection, 
the bacteria are in a compartment that is not competent to mi-
grate, suggesting that slow growth of   M. tuberculosis   in the lungs 
does not fully account for delayed T cell activation. Collec-
tively, these results indicate that during early stages of infec  tion 
in vivo,   M. tuberculosis   occupies one or more compartments that 
do not promote antigen presentation to naive CD4  +   T cells, 
and this allows dramatic expansion of the bacterial population 
    Figure 6.           M. tuberculosis   disseminates and activates P25TCR-Tg CD4  +   T cells in lymphoid tissues that do not drain the lungs.   (A) Bacterial load 
in the mediastinal lymph node (MLN), spleen, and inguinal lymph node (ILN) with time. The dashed line represents the limit of detection (18.75 cfu/mouse). 
Error bars represent the SD. (B) The percentage of P25TCR-Tg CD4  +   T cells that have undergone at least 1 cycle of proliferation in the mediastinal lymph 
node (MLN), spleen, and inguinal lymph node (ILN). Error bars represent the SEM. (C) CFSE histograms form the inguinal lymph node at days 17 and 21 after 
infection; each histogram represents one mouse. Values in the top left corner represent the number of cfu found in the inguinal lymph node of that mouse.     112 INITIATION OF T CELL RESPONSES TO   MYCOBACTERIUM TUBERCULOSIS   | Wolf et al.
of   M. tuberculosis   antigens. However, we found that the tem-
poral and quantitative characteristics of expansion of adop-
tively transferred Ag85B-specifi  c CD4  +   T cells paralleled that 
of total CD4  +   T cell responses during the course of   M. tuber-
culosis   infection (  Fig. 2  ). Moreover, our results correspond 
closely to those obtained by ex vivo restimulation with an 
  M. tuberculosis   lysate (  5  ). 
  The observation that initial Ag85B-specifi  c CD4  +   T cell 
responses require the presence of live bacteria in the lymph 
node suggests that the time required for   M. tuberculosis   to en-
ter a compartment that is competent for transport to the local 
lymph node may account for the delay in initiation of the 
adaptive immune response in tuberculosis. Although slow 
replication of   M. tuberculosis   could be assumed to account for 
the delayed cellular immune response, our data imply that 
slow bacterial growth cannot fully explain the temporal char-
acteristics of the immune response. If a simple model of slow 
growth accounted for insuffi   cient antigen for CD4  +   T cell 
activation, the time required to initiate the immune response 
should be reduced by a higher inoculum of bacteria. For ex-
ample, increasing the inoculum from 100 to 700 bacteria/
mouse in the initial inoculum should have reduced the time 
dependence of Ag85B-specifi  c CD4  +   T cell activation by 
    2.6 bacterial doubling times (71 h, based on the growth 
curve shown in   Fig. 1  ). Instead, we found no diff  erence in 
the time required to initiate proliferation of Ag85B-specifi  c 
CD4  +   T cells in mice infected with 100 or 700 bacteria, 
which implies that one or more factors other than a low initial 
inoculum contribute to the long interval preceding Ag85B-
specifi  c CD4  +   T cell responses. 
  We recently reported that, after aerosol infection of mice 
with   M. tuberculosis  , myeloid dendritic cells become infected 
in the lungs, and represent the predominant cells that con-
tain   M. tuberculosis   in the mediastinal lymph node (  13  ). More-
over, we found that plt mice exhibited a parallel decrease in 
dendritic cell recruitment and dissemination of   M. tuberculosis   
to the mediastinal lymph node. These results provide evidence 
that myeloid dendritic cells become infected in the lungs 
and transport live   M. tuberculosis   to the local lymph node. 
Together with the observation that plt mice also show an in-
creased delay in activation of Ag85B-specifi  c CD4  +   T cells 
(  Fig. 5  ), these results suggest that myeloid dendritic cell trans-
port of   M. tuberculosis   to the local lymph node is a critical de-
terminant of the initiation of the adaptive immune response 
in tuberculosis. 
  Because transport of   M. tuberculosis   to the mediastinal 
lymph node was not apparent until 11  –  12 d after infection, 
we tested the hypothesis that administration of lipopoly-
saccharide to   M. tuberculosis    –  infected mice would accelerate 
migration of infected dendritic cells from the lungs to the 
mediastinal lymph node, and thereby accelerate activation of 
Ag85B-specifi  c CD4  +   T cells. Although intranasal adminis-
tration of lipopolysaccharide did result in recruitment of 
additional macrophages and dendritic cells to the lungs of 
infected mice, and resulted in recruitment of additional den-
dritic cells to the mediastinal lymph node, this did not result 
lymph node. These results indicate that, even for an abundant 
secreted protein antigen, stimulation of CD4  +   T cells requires 
short-range interactions between   M. tuberculosis    –  infected cells 
and antigen-specifi  c T cells. 
  We considered the possibility that the immune response to 
  M. tuberculosis   Ag85B is aberrant or otherwise unrepresentative 
    Figure 7.         Airway administration of LPS does not increase trans-
location of   M. tuberculosis   from the lungs to the mediastinal lymph 
node, and does not accelerate P25TCR-Tg CD4  +   T cell responses.  
Mice that were either uninfected or infected 10 d earlier with wild-type 
  M. tuberculosis   received  5   ×   10 6   CFSE-labeled P25TCR-Tg CD4  +   T cells 4 d 
before harvest. 24 h later, i.e., 3 d before harvest, mice were given sterile 
PBS or 1     g LPS with or without 50 ng of recombinant Antigen 85B 
(rAg85B) by the intranasal route. (A) The number of myeloid dendritic cell 
in the mediastinal lymph node. (B) Surface MHC class II mean fl  uorescence 
intensity (MFI) on mediastinal lymph node myeloid dendritic cell. (C) Cfu 
in the lung and mediastinal lymph node (MLN) in mice infected with wild-
type   M. tuberculosis   that either received PBS or LPS i.n. (D) Change in the 
number of P25TCR-Tg CD4  +   T cells caused by proliferation as assessed in 
the mediastinal lymph node at day 14 after infection (4 d after LPS or 
control). Histograms show day 14 CFSE proliferation profi  les of represen-
tative mice given either PBS (D, left) or LPS (D, right) i.n. (E) Comparison of 
the number of P25TCR-Tg CD4  +   T cells in the mediastinal lymph node of 
uninfected or   M. tuberculosis –   infected mice that received either PBS or 
rAg85B + LPS i.n. Histograms represent the proliferation profi  le of the CFSE-
labeled P25TCR-Tg cells in uninfected + rAg85B + LPS (left) and infected 
+ rAg85B + LPS (right). The number of cells was determined by multiplying 
the percentage as determined by fl  ow cytometry by the total number of 
cells in the lymph node as assessed by trypan exclusion. Three mice were 
examined per group, and the error bars represent the SD. Statistics were 
done using Student   t   test. *, P   <   0.05; **, P   <   0.01. ns, not signifi   cant.   JEM VOL. 205, January 21, 2008 
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  Generation and characterization of Antigen 85B  –  defi  cient   M. tuberculosis  .   
  Antigen 85B (Rv1886c)  –  defi  cient   M. tuberculosis   mutant was created with the 
conditionally replicating mycobacteriophages, as previously described (  37  ). 
The upper and lower allelic exchange substrates were PCR amplifi  ed from 
H37Rv genomic DNA and cloned into pCR2.1-TOPO (Invitrogen). 
The allelic exchange substrates were sequenced and directionally cloned into 
pYUB854. After transduction of H37Rv and plating on Middlebrook 7H9 
agar supplemented with albumin-dextrose-catalase, several colonies were 
picked and screened for the absence of Antigen 85B mRNA by real-time 
RT-PCR. Antigen 85B  –  defi  cient clones (Ag85BKO-Mtb) were also exam-
ined by Western blot to confi  rm the absence of Antigen 85B protein using a 
monoclonal antibody against the Antigen 85B complex. 
  Preparation and characterization of recombinant Antigen 85B.   
  Recombinant Antigen 85B was produced using the expression plasmid pM-
RLB47.Rv1886c obtained through the National Institutes of Health TB 
Vaccine Testing and Research Materials Contract (NIAID N01AO040091). 
  Escherichia coli   BL21(DE3)pLysS (Novagen) was transformed with the expres-
sion plasmid. Bacteria were grown in Lurie-Bertani broth at 37  °  C until 
OD  600   = 0.5, and then the culture was shifted to 30  °  C in the presence of 0.5 mM 
IPTG. Lysis of   E. coli   and extraction of recombinant protein was done using 
BugBusters reagent and His-Bind kit (Novagen) according to the manufac-
turer  ’  s instructions, followed by dialysis in PBS and quantitation using BCA 
Protein Assay (Thermo Fisher Scientifi  c). Protein purity was assessed by SDS-
PAGE and Bio-Safe Coomassie staining (Bio-Rad Laboratories). Endotoxin 
was removed using EndoClean reagent (BioVintage). Recombinant Antigen 
85B was considered endotoxin-free when it was determined to contain   <  0.1 
EU/ml as assessed by PyroGene Recombinant Factor C Endotoxin Detection 
System (Cambrex). 
  In vitro T cell stimulation assays.     BM-derived macrophages (BMDMs) 
from C57BL/6 mice were cultured as previously described (  38  ). After 6  –  7 d of 
culture, cells were replated at 10  5   cells/well in fl  at bottom 96-well plates and 
treated for 24 h with recombinant mouse IFN     (20 ng/ml; BD Biosciences). 
For infection of cultured cells,   M. tuberculosis   H37Rv was grown to an OD  580   
of 0.5  –  1 in 7H9 broth supplemented with albumin-dextrose-catalase enrich-
ment. A suspension of single bacteria was generated by pelleting the bacteria, 
resuspending in macrophage culture media, and allowing the bacteria to fl  ow 
by gravity through a 5-    m syringe fi  lter (Millipore) to remove clumps. Bac-
teria were enumerated by counting a dilution in a Petroff  -Hausser chamber 
and confi  rmed by serial dilution and growth on 7H11 agar. BMDMs were 
incubated with bacteria for 24 h in BMDM growth media. Growth media 
was removed and extracellular bacteria were removed by washing with PBS. 
P25TCR-Tg CD4  +   T cells were added at 2   ×   10  5   cells/well in complete 
media (RPMI, 10% FCS,   l-  glutamine, nonessential amino acids, sodium py-
ruvate, Hepes, and     -mercaptoethanol) with or without peptide 25 (custom 
synthesis by Invitrogen and EZ Biolabs), and cells were incubated for 1  –  5 d. 
Supernatants of triplicate wells were pooled and assayed for IFN     by ELISA 
(BD Biosciences) and read on a Bio Tek EXL800 plate reader, or prolifera-
tion of CFSE-labeled P25TCR-Tg/Rag1      /      CD4  +   T cells was assessed by 
fl  ow cytometry. 
  P25TCR-Tg CD4  +   T cell isolation and labeling.     P25TCR-Tg mice 
between 8  –  16 wk of age were killed according to approved laboratory ani-
mal procedures. Lymph nodes and spleen were aseptically removed, and tis-
sues were disrupted by forcing them through a 70-    m cell strainer (BD 
Biosciences) in RPMI, 5% FCS, 10 mM Hepes. Red blood cells were re-
moved using ACK lysis buff  er (155 mM NH  3  Cl, 10 mM KHCO  3  , and 88     M 
EDTA). Live cells were counted in a hemacytometer using trypan blue 
exclusion. CD4  +   T cells were magnetically isolated using a CD4  +   T Cell 
Isolation kit and an AutoMACS (Miltenyi Biotech). CD4  +   T cell purity was 
routinely   >  90% as assessed by fl  ow cytometry. For proliferation assays, CD4  +   
T cells were labeled with CFSE by resuspending the P25TCT-Tg CD4  +   cells at 
a density of 10  7   cells/ml in room temperature PBS containing 1     M CFSE 
(CFDA-SE; Invitrogen). Cells were incubated with CFSE for 7 min at 37  °  C. 
in an increase in the number of bacteria transported to the 
lymph node, and did not result in increased activation of 
Ag85B-specifi  c CD4  +   T cell responses. These results imply 
that during the early stage of   M. tuberculosis   infection, the 
bacteria are in a cellular compartment that is unable to migrate 
from the lungs to the lymph node. Whether the bacteria are in 
cells that intrinsically lack the ability to migrate, or whether 
they inhibit migration of dendritic cells from the lungs to the 
lymph node, will require further study. 
  The fi  ndings reported here have several implications for 
understanding the biology of tuberculosis. In particular, they 
indicate that even though the lungs are the site of infection 
with   M. tuberculosis  , the cellular immune response is not initi-
ated in the lungs. This is consistent with the well-characterized 
traffi   cking patterns of naive T lymphocytes that circulate 
through peripheral nonlymphoid organs with low frequency 
(  25, 26  ). Therefore, even though a large number of bacteria 
are present and a large quantity of antigen is produced by bac-
teria in the lungs (  24  ), initiation of the adaptive immune re-
sponse requires transport of bacteria from the lungs to the local 
draining lymph node or other secondary lymphoid tissues. 
Second, the observation that the bacterial population in the 
lungs expands 10,000  –  100,000-fold between the time of initial 
infection and appearance of the adaptive immune response in 
the lungs implies that the eff  ector mechanisms of the adaptive 
immune response confront a large bacterial burden when they 
do appear in the lungs. Because   M. tuberculosis   has been found 
to inhibit cellular responses to IFN     (  27  –  30  ) and MHC class II 
antigen presentation (  31  –  33  ), the existence of such a large bac-
terial population in the lungs may interfere with recognition 
by and/or eff  ector functions of CD4  +   T cells, and thereby in-
hibit the ability of the adaptive immune response to eradicate 
  M. tuberculosis   from the lungs. Third, these fi  ndings may pro-
vide a basis for further analysis of the diff  erential outcomes in 
humans infected with   M. tuberculosis  . Although a high propor-
tion of humans that encounter   M. tuberculosis   develop immune 
responses that contain the infection as latent tuberculosis,     5% 
progress to active, symptomatic infection within 2 yr of initial 
infection (  34  ). Although identifi  able factors such as HIV infec-
tion account for some cases of progressive infection (  35  ), most 
are unexplained. The fi  ndings reported here from studies of 
mice suggest that variations in transport of bacteria from the 
lungs to the local lymph node and initiation of the adaptive 
immune response may underlie some of the diff  erential out-
comes of   M. tuberculosis   infection in humans. 
    MATERIALS AND METHODS   
  Mice.     P25TCR-Tg mice, whose CD4  +   T cells express a transgenic T-cell 
antigen receptor that recognizes peptide 25 (aa 240  –  254) of   M. tuberculosis   
Antigen 85B bound to I-A  b   was prepared on a C57BL/6 background, as pre-
viously described (  36  ). Mice for experiments were bred in the New York 
University School of Medicine animal facility. Genotypes of all mice were 
confi  rmed by PCR testing of tail genomic DNA. CD45.1 mice were either 
bred in the New York University School of Medicine animal facility or 
purchased from Taconic Farms, Inc. All animal experiments were done in 
accordance with procedures approved by the New York University School of 
Medicine Institutional Animal Care and Use Committee. 114 INITIATION OF T CELL RESPONSES TO   MYCOBACTERIUM TUBERCULOSIS   | Wolf et al.
relative to the number of cycles of P25TCR-Tg proliferation in the lung 
and mediastinal lymph node. The online version of this article is available at 
http://www.jem.org/cgi/content/full/jem.20071367/DC1. 
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cell strainer (BD Biosciences), and plating the homogenate on 7H11 agar. 
Plates were incubated at 37  °  C, and colonies were counted 14  –  21 d later. 
  Tissue processing and fl  ow cytometry.     At designated time points, 3  –  5 
infected mice in each group were killed, and tissues were used to prepare 
single-cell suspensions, as previously described (  13  ), with the exception that 
enzyme digestion was omitted when tissues were used only for T cell isolation. 
5   ×   10  6   cells were stained with anti-CD4, anti-CD45.2, and other surface 
marker antibodies at a density of 1.5   ×   10  7   cells/ml in FACS buff  er (PBS, 1% 
FCS, 0.1% sodium azide, and 1 mM EDTA) and incubated at 4  °  C for 20  –  30 
min. Cells were washed and fi  xed in 1% PFA overnight at 4  °  C. Data were 
acquired on either a FACSCalibur or LSRII (BD Biosciences). Flow cytom-
etry antibodies were purchased from BD Biosciences or BioLegend. The 
number of cells of a specifi  c phenotype was determined by taking the per-
centage of that cell type determined by fl  ow cytometry multiplied by the 
number of total cells.   “  Percent proliferating  ”   was defi  ned as the percentage of 
all P25TCR-Tg CD4  +   T cells that had undergone at least one cycle of repli-
cation.   “  Percent divided  ”   was defi  ned as the percentage of the original num-
ber of P25TCR-Tg CD4  +   T cells that have begun to proliferate assuming no 
cell death, calculated by FlowJo (Tree Star, Inc.) proliferation platform. 
  Detection of IFN    -producing cells by intracellular cytokine staining.   
  Single-cell suspensions of lung and lymph node were prepared as in the previous 
section. Cells were plated at 10  6   cells per well in a round-bottom 96-well 
tissue culture plate (Corning) in complete media. 5  –  7 wells of cells were plated 
for each mouse and incubated with or without 10     g of peptide 25 per well 
for 4  –  6 h in the presence of Brefeldin A at 37  °  C with 5% CO  2  . Cells were 
stained for the surface markers CD4 and CD45.2 for 30 min at 4  °  C, followed 
by fi  xation for 2 h at 4  °  C in 2% PFA. IFN     was detected using Cytofi  x/
Cytoperm kit (BD Biosciences) according to the manufacturer  ’  s instructions. 
Data were acquired on an LSR-II fl  ow cytometer using FACSDiva Software 
(BD Biosciences) and analyzed using FlowJo software. 
  Determination of bacterial load.     At every time point, each tissue from 
each mouse was assessed for bacterial load by taking an aliquot of the total tis-
sue homogenate before any washing. The aliquot was serial diluted and plated 
on 7H11 agar. Plates were incubated at 37  °  C and colonies were counted 
14  –  21 d later. Total colony forming units were determined based on the total 
volume of tissue homogenate. 
  Intranasal and subcutaneous immunization with recombinant Anti-
gen 85B.       M. tuberculosis  –    infected or uninfected mice were anesthetized with 
a mixture of ketamine and xylazine administered i.p., and given sterile PBS 
with or without 50 ng of endotoxin-free recombinant Antigen 85B in 30  –  50     l 
of sterile PBS, together with 1     g of LPS for intranasal immunization or in an 
emulsion of TiterMax adjuvant (Sigma-Aldrich) for subcutaneous immuni-
zation. 3 d after immunization, tissues were harvested and single-cell suspensions 
were analyzed by fl  ow cytometry and plated for cfu, as described above. 
  Online supplemental material.     An analysis of the in vitro response of 
P25TCR-Tg T cells to Antigen 85B, peptide 25, and   M. tuberculosis    –  infected 
cells can be found in Fig. S1. Fig. S2 shows the P25TCR-Tg T cell responses 
to intranasal and subcutaneous immunization with Ag85B, demonstrating 
that the transgenic T cells do not display inherently delayed responsiveness. 
The expression patterns of CD69, CD25, and IFN     on P25TCR-Tg T cells 
over the course of the infection in the lung and mediastinal lymph node 
are depicted in Fig. S3. In addition, Fig. S3 shows the expression of IFN     JEM VOL. 205, January 21, 2008 
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